ES2174930T3 - Composiciones de metronidazol de liberacion modificada y metodos para preparar y utilizar las mismas. - Google Patents
Composiciones de metronidazol de liberacion modificada y metodos para preparar y utilizar las mismas.Info
- Publication number
- ES2174930T3 ES2174930T3 ES95907963T ES95907963T ES2174930T3 ES 2174930 T3 ES2174930 T3 ES 2174930T3 ES 95907963 T ES95907963 T ES 95907963T ES 95907963 T ES95907963 T ES 95907963T ES 2174930 T3 ES2174930 T3 ES 2174930T3
- Authority
- ES
- Spain
- Prior art keywords
- metronidazole
- aqueous
- compositions
- methods
- aqueous soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 title abstract 8
- 229960000282 metronidazole Drugs 0.000 title abstract 8
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000003085 diluting agent Substances 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 239000008187 granular material Substances 0.000 abstract 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE DESCRIBEN COMPOSICIONES FARMACEUTICAS CON UN PERFIL DE LIBERACION MODIFICADO PARA LA ADMINISTRACION UNA VEZ/DIA DE METRONIDAZOL, LOS METODOS PARA PREPARAR LAS COMPOSICIONES FARMACEUTICAS Y LOS METODOS PARA TRATAR UNA INFECCION MICROBIANA CON LA ADMINISTRACION 1 VEZ/DIA DE LAS COMPOSICIONES FARMACEUTICAS. LAS COMPOSICIONES ADMINISTRADAS UNA VEZ/DIA SON BIOEQUIVALENTES AL METRONIDAZOL DE LIBERACION INMEDIATA ADMINISTRADO 3 VECES/DIA. LAS COMPOSICIONES DE LA INVENCION CONTIENEN: (A) UNA PRIMERA PARTE DE METRONIDAZOL, ENTRE 59 Y 79% POR PESO, APROXIMADAMENTE; (B) APROXIMADAMENTE 1,5 A 3,0% POR PESO DE UN COPOLIMERO ESTERIFICADO DE POLIMETACRILATO, INSOLUBLE EN AGUA, PERMEABLE AL AGUA, EXPANSIBLE EN AGUA E INDEPENDIENTE DE PH; (C) APROXIMADAMENTE 0,1 A 2,0 % POR PESO DE UN DESVISCOSIFICADOR; (D) 0 A APROXIMADAMENTE 23% POR PESO DE UN DILUYENTE FARMACEUTICO SOLUBLE EN AGUA; (E) 0 A APROXIMADAMENTE 23% POR PESO DE UN SEGUNDO DILUYENTE SOLUBLE EN AGUA, ADECUADO PARA FORMAR UN COMPRIMIDO FARMACEUTICO AL COMPRIMIRSE CON GRANULOS DE (A), Y DISTINTO O IGUAL AL PRIMER DILUYENTE SOLUBLE EN AGUA; (F) 0 A APROXIMADAMENTE 20% POR PESO DE UNA SEGUNDA PARTE DE METRONIDAZOL; (G) 0 A APROXIMADAMENTE 0,2% POR PESO DE GLIDANTE Y (H) 0 A APROXIMADAMENTE 2% POR PESO DE LUBRICANTE. LA COMPOSICION CONTIENE GRANULOS DE METRONIDAZOL COMPUESTOS POR (A), (B), (C), Y (D). LA SUMA DE LOS PORCENTAJES POR PESO DE METRONIDAZOL COMPUESTOS POR (A) Y (F) ES ENTRE 70 Y 79% POR PESO, APROXIMADAMENTE Y LA SUMA DE LOS PORCENTAJES POR PESO DE DILUYENTE SOLUBLE EN AGUA COMPUESTO POR (D) Y (E) ES ENTRE 16 Y 23% POR PESO, APROXIMADAMENTE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/187,568 US6103262A (en) | 1994-01-27 | 1994-01-27 | Modified-release metronidazole compositions and methods for making and using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2174930T3 true ES2174930T3 (es) | 2002-11-16 |
Family
ID=22689500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95907963T Expired - Lifetime ES2174930T3 (es) | 1994-01-27 | 1995-01-04 | Composiciones de metronidazol de liberacion modificada y metodos para preparar y utilizar las mismas. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6103262A (es) |
| EP (1) | EP0744947B1 (es) |
| JP (1) | JPH09508381A (es) |
| KR (1) | KR100368769B1 (es) |
| CN (1) | CN1095665C (es) |
| AT (1) | ATE216236T1 (es) |
| AU (1) | AU682248B2 (es) |
| BR (1) | BR9506662A (es) |
| CA (1) | CA2181985C (es) |
| DE (1) | DE69526434T2 (es) |
| DK (1) | DK0744947T3 (es) |
| ES (1) | ES2174930T3 (es) |
| MX (1) | MX9602951A (es) |
| NZ (1) | NZ279368A (es) |
| PT (1) | PT744947E (es) |
| WO (1) | WO1995020383A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8588898A (en) | 1997-07-28 | 1999-02-16 | Mary L. Redmond | Composition and process for the treatment of epidermal traumas such as decubitusulcers |
| US6322819B1 (en) * | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
| DE19850445A1 (de) * | 1998-11-02 | 2000-05-04 | Falk Pharma Gmbh | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen |
| ECSP003851A (es) * | 1999-12-22 | 2002-05-23 | Pharmacia Corp | Composicon de liberacion doble de un inhibidor ciclooxigenasa-2 |
| US6423707B1 (en) | 2000-08-28 | 2002-07-23 | California Pacific Medical Center | Nitroimidazole ester analogues and therapeutic applications |
| US8846100B2 (en) * | 2006-05-12 | 2014-09-30 | Shire Llc | Controlled dose drug delivery system |
| WO2012075015A2 (en) | 2010-11-29 | 2012-06-07 | Dr. Reddy's Laboratories Ltd. | Oral metronidazole pharmaceutical compositions |
| EP2806861A1 (en) * | 2012-01-23 | 2014-12-03 | Ranbaxy Laboratories Limited | In-situ multilayered tablet technology |
| JP6487534B2 (ja) | 2014-09-05 | 2019-03-20 | シンビオミックス セラピューティクス、エルエルシー | 細菌性膣炎の治療に使用するためのセクニダゾール |
| US11253501B2 (en) | 2015-06-01 | 2022-02-22 | Lupin Inc. | Secnidazole formulations and use in treating bacterial vaginosis |
| US11547675B2 (en) * | 2015-08-10 | 2023-01-10 | Purdue Research Foundation | Methods and systems for depositing active ingredients on substrates |
| GR1008992B (el) | 2015-12-17 | 2017-03-23 | Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων | Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης |
| CN112007002B (zh) * | 2020-08-05 | 2022-08-12 | 河北君临药业有限公司 | 一种质量稳定的甲硝唑片剂组合物及其制备方法 |
| US12280037B2 (en) | 2020-09-22 | 2025-04-22 | Evofem Biosciences, Inc. | Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof |
| US11826477B1 (en) * | 2022-06-17 | 2023-11-28 | Imam Abdulrahman Bin Faisal University | Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2944061A (en) * | 1957-09-20 | 1960-07-05 | Acyl derivatives and process | |
| FI63335B (fi) * | 1979-02-02 | 1983-02-28 | Orion Yhtymae Oy | Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne |
| JPS6056122B2 (ja) * | 1980-05-21 | 1985-12-09 | 塩野義製薬株式会社 | 徐放性製剤 |
| GB8707416D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
| US4927639A (en) * | 1989-02-02 | 1990-05-22 | Warner-Lambert Company | Modified release gemfibrozil composition |
| DE4125048A1 (de) * | 1991-07-29 | 1993-02-04 | Peggy Albrecht | Arzneimittel mit verzoegerter freisetzung zur behandlung von periodontitis |
| CA2093282C (en) * | 1992-05-04 | 1999-01-12 | Tibor Sipos | Intraoral medicament-releasing device |
-
1994
- 1994-01-27 US US08/187,568 patent/US6103262A/en not_active Expired - Fee Related
-
1995
- 1995-01-04 CA CA002181985A patent/CA2181985C/en not_active Expired - Fee Related
- 1995-01-04 WO PCT/US1995/000005 patent/WO1995020383A1/en not_active Ceased
- 1995-01-04 KR KR1019960703863A patent/KR100368769B1/ko not_active Expired - Fee Related
- 1995-01-04 NZ NZ279368A patent/NZ279368A/en unknown
- 1995-01-04 DK DK95907963T patent/DK0744947T3/da active
- 1995-01-04 BR BR9506662A patent/BR9506662A/pt not_active IP Right Cessation
- 1995-01-04 JP JP7520048A patent/JPH09508381A/ja not_active Ceased
- 1995-01-04 MX MX9602951A patent/MX9602951A/es not_active IP Right Cessation
- 1995-01-04 ES ES95907963T patent/ES2174930T3/es not_active Expired - Lifetime
- 1995-01-04 DE DE69526434T patent/DE69526434T2/de not_active Expired - Fee Related
- 1995-01-04 CN CN95191364A patent/CN1095665C/zh not_active Expired - Fee Related
- 1995-01-04 PT PT95907963T patent/PT744947E/pt unknown
- 1995-01-04 AT AT95907963T patent/ATE216236T1/de not_active IP Right Cessation
- 1995-01-04 EP EP95907963A patent/EP0744947B1/en not_active Expired - Lifetime
- 1995-01-04 AU AU15967/95A patent/AU682248B2/en not_active Ceased
- 1995-05-19 US US08/445,309 patent/US5618559A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE216236T1 (de) | 2002-05-15 |
| DE69526434T2 (de) | 2002-10-31 |
| CN1095665C (zh) | 2002-12-11 |
| CN1139382A (zh) | 1997-01-01 |
| AU1596795A (en) | 1995-08-15 |
| NZ279368A (en) | 1998-04-27 |
| WO1995020383A1 (en) | 1995-08-03 |
| MX9602951A (es) | 1997-06-28 |
| JPH09508381A (ja) | 1997-08-26 |
| EP0744947A1 (en) | 1996-12-04 |
| US5618559A (en) | 1997-04-08 |
| CA2181985C (en) | 2000-12-05 |
| US6103262A (en) | 2000-08-15 |
| DE69526434D1 (de) | 2002-05-23 |
| KR100368769B1 (ko) | 2003-05-16 |
| AU682248B2 (en) | 1997-09-25 |
| DK0744947T3 (da) | 2002-07-29 |
| CA2181985A1 (en) | 1995-08-03 |
| EP0744947B1 (en) | 2002-04-17 |
| PT744947E (pt) | 2002-08-30 |
| BR9506662A (pt) | 1997-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT744947E (pt) | Composicoes de metronidazole com libertacao modificada e metodos para os fazer e utilizar | |
| IL111647A0 (en) | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them | |
| EA200000584A2 (ru) | Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием | |
| ATE97930T1 (de) | Biologisch abbaubare poly-(hydroxyalkyl)aminodicarbons|ure-derivate, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe. | |
| IL115357A0 (en) | Stabel compositions containing n-propargyl-1-aminoindan | |
| DE60019693D1 (de) | Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten | |
| MXPA04011914A (es) | Formulacion farmaceutica de liberacion modificada. | |
| WO2007000778A3 (en) | Modified release pharmaceutical compositions on the basis of two polymers and processes thereof | |
| ATE258044T1 (de) | Verfahren zur herstellung einer mit bändern versehenen dosisform zur verlängerten freisetzung eines wirkstoffs | |
| BR0007589A (pt) | Inibidores da proliferação de células | |
| ES2185911T3 (es) | Composiciones farmaceuticas que contienen polimeros de ortoester tamponados. | |
| DE69726457D1 (de) | Pharmazeutische zusammensetzungen mit antimikrobieller wirkung | |
| HUP0401811A2 (hu) | Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására | |
| DE69409337D1 (de) | Verzweigte Aminothiazole-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammenstellungen die sie enthalten | |
| PT1195160E (pt) | Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação | |
| AU3483497A (en) | Solid solution of an antifungal agent with enhanced bioavailability | |
| NO960632D0 (no) | Nye bis-naftalimider for behandling av kreft | |
| SI1534352T1 (sl) | Vsadek za transport in sproščanje farmakoloških učinkovin, kot tudi postopek za proizvodnjo le-tega | |
| AU2360592A (en) | Polyacrylic acid based ophthalmic compositions | |
| DK1216043T3 (da) | Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater) | |
| DK0764169T3 (da) | Lægemiddelsalte | |
| DK0542979T3 (da) | Terapeutisk sammensætning til langsom frigivelse af magnesium | |
| DK0815109T3 (da) | Fremgangsmåde til fremstilling af estere af anhydroecgonin | |
| ES2079997A1 (es) | Compuestos de fenil fenol sustituidos antagonistas de leucotrieno, procedimiento para su obtencion y formulaciones farmaceuticas de los mismos. | |
| ATE292627T1 (de) | Hydroxamsäurederivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 744947 Country of ref document: ES |